The genes identified in this study (CDKN1A, HIF1A, MXD1, and SOD2) were significantly upregulated in lung tissues in two different clinical COPD transcriptomics datasets, and had the potential to develop as therapeutics targets of COPD. Here, SOD2 is linked to chronic obstructive pulmonary disease.